Windtreetx

Windtreetx

Windtreetx

Windtree Therapeutics, Inc. is a #biotech company focused on developing novel KL4 surfactant therapies for respiratory diseases and other potential applications
Type
B2b
Raised
$10.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$10,500,000
Post-IPO equity - 2017
Team Size
1–10
Employees
$10,500,000 Post-IPO equity
prnewswire

Windtree Therapeutics Completes $10.5 Million Private Offering